Elsevier Wins Frost & Sullivan's Technology Innovation Award for Its STATdx and ExpertPath Diagnostic Decision Support Systems
Elsevier is improving the outlook on diagnostic decision-making through its expert-based decision support solutions for radiologists and pathologists
SANTA CLARA, California, Nov. 16, 2017 /PRNewswire/ -- Based on its recent analysis of clinical decision support systems (CDSS) for the pathology and radiology industry, Frost & Sullivan recognizes Elsevier with the 2017 North America Technology Innovation Award for its ExpertPath™ and STATdx® industry-leading diagnostic support systems for pathologists and radiologists. An established leader in the CDSS market, Elsevier offers a variety of content sources integrated with evidence-based content for the care process to help improve patient outcomes.
Click here for the full multi-media experience of this release – http://bit.ly/2hrc0tp
Widely regarded as the "Gold Standard" of radiology reference solutions, STATdx serves more than 50,000 users across 100 countries and is used in 99% of Academic Hospitals in North America. Written by renowned radiologists in each specialty, STATdx increases accuracy and confidence in diagnosing complex imaging cases and includes over 4,000 common and complex diagnoses, 200,000 expert-selected and annotated image examples, more than 1,300 differential diagnosis modules, 20,000 easily sortable patient cases with cine clips for select topics, and much more.
ExpertPath is an anatomic and clinical pathology online decision support solution that provides timely aid to today's pathologists in their quest to get every diagnosis right and provide critical information back to physicians and care teams. ExpertPath equips pathologists working under high pressure with the expert-based information needed for: diagnosing complex or unusual cases; examining a case in an unfamiliar specialty area; teaching students and residents; preparing for a lecture; and taking part in or preparing for a tumor board Content includes differential diagnosis lists, ancillary tests, image galleries and specimen-handling protocols.
"With the shift in healthcare to digitalization, CDSS combines emerging Big Data and artificial intelligence technologies for improved clinical assessments. As a leader in the CDSS market, Elsevier knows the worth of extensive information, but the company also understands that the information must be easily accessible to optimize its value in diagnostic decisions," states Frost & Sullivan's Divyaa Ravishankar, Industry Principal. "Elsevier designed its solutions to push relevant and easily searchable data, ensuring physicians are not overburdened with non-relevant information."
Elsevier's platform content is available in nine languages—Simplified Chinese, Traditional Chinese, Spanish, Portuguese, Brazilian Portuguese, Italian, German, French, and Japanese—facilitating access for global users.
"Elsevier's customer support is outstanding. They have expert teams working to guarantee the reference material is the most up-to-date available, in addition to providing a field service team to help new customers use the platform efficiently for improved clinical utility," said Ravishankar. "The company is ahead of the curve regarding what customers need. While the radiology health segment transitioned to digitalization a decade ago, the pathology segment is just starting to embrace it, so the ExpertPath solution comes at the right time for the right people."
Elsevier is creating innovative products, such as STATdx and ExpertPath, providing physicians easy access to relevant information for improved clinical assessments. For this reason, Elsevier earns Frost & Sullivan's 2017 North America Technology Innovation Award.
Each year, Frost & Sullivan presents this award to the company that develops products with innovative features and functionality that are gaining rapid acceptance in the market. The award recognizes the quality of the solutions and the customer value enhancements they enable.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About Elsevier
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Media Contacts:
Christopher Capot
Director, Global Communications
Elsevier
+1 917 704 5174
c.capot@elsevier.com
Andrea Steinman
Frost & Sullivan
P: 210.477.8425
F: 210.348.1003
E: Andrea.steinman@frost.com
Share this article